Back to Top Skip to main content

Understanding the potential of COVID-19 convalescent plasma

Researcher scans a unit of plasma in lab. U.S. Army Sgt. Reginald Miles labels donated liquid plasma at the Landstuhl Blood Donor Center. Researchers are studying COVID-19 convalescent plasma to harness the power of neutralizing antibodies to help patients. (Photo by Volker Ramspott)

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | Armed Services Blood Program

The Department of Defense has set a goal to collect more than 8,000 donated units of plasma from patients who have recovered from COVID-19 by Sept. 30, 2020. This blood will be used to treat critically ill patients and support the development of an effective treatment against the disease.

Like a missile locking on its target, antibodies attack invaders inside the body with a singularity of purpose: search and destroy. Typically, infection-fighting white blood cells produce antibodies as an appropriate response to an invading germ. In some people whose immune systems can’t mount a sufficient attack against a virus, donated antibodies from another person’s plasma may help. Researchers believe the power of antibodies lies in their ability to bind to a virus and neutralize it, or block it from entering cells, said Dr. Kayvon Modjarrad, director of the Emerging Infectious Diseases Branch at the Walter Reed Army Institute of Research in Silver Spring, Maryland. Modjarrad leads the Army’s COVID-19 vaccine development research.

But not all antibodies are created the same. “Antibodies come in different flavors, some of them are neutralizing and some of them are non-neutralizing and we don’t know exactly which individuals are developing what type of antibody,” said Shelly Krebs, chief of B Cell Biology Core at WRAIR Military HIV Research program.

COVID-19 convalescent plasma, or CCP, from a recovered patient could be a mixture of both neutralizing and non-neutralizing antibodies. In fact, people infected with COVID-19 can have varying antibody responses. Some may not have enough antibodies in their plasma to benefit another patient, which is why CCP first needs to be tested for neutralizing antibody levels before transfusing, explained Modjarrad. His lab works to understand the mechanism of COVID-19 antibodies to predict the levels required to offer a person protection from the virus.

Transfusing antibodies provides short-term immunity as the donor antibodies last several weeks to months inside the body, said Navy Capt. (Dr.) Todd Gleeson of the Navy Bloodborne Infection Management Center, located at Naval Support Activity Bethesda, Maryland. “It is likely that a person with COVID-19 who receives CCP will also still develop their own immune cells and produce antibodies to fight the virus if that person is re-exposed in the future,” said Gleeson, who leads a convalescent plasma study of patients at Walter Reed National Military Medical Center also at NSAB in Bethesda. But scientists just can’t confirm that yet. They hope to uncover the answer and many more as they study CCP and COVID-19 antibodies to better treat patients and develop future vaccines.

Military medical treatment facilities will soon take part in an observational study across the Department of Defense to help researchers track trends among patients with COVID-19. The data will help trace recovered patients to ask for CCP donations as the DoD seeks to build a storehouse of CCP for patients admitted to Military Health System facilities and those deployed outside the U.S., explained Army Col. (Dr.) Andrew Cap, director of research at the Army Institute of Surgical Research in San Antonio, Texas. “The goal is to build a convalescent plasma capability within the DoD, both on the collection and on the treatment side,” said Cap, who helped draft a CCP protocol for the DoD.

Future research may lead to the development of highly concentrated neutralizing antibodies extracted from large quantities of convalescent plasma as a potential therapy for prevention and treatment, added Cap.

Scientists believe monoclonal antibodies—derived from a single immune cell—may also hold potential as both a treatment and preventive measure against COVID-19. Krebs and her team have engineered monoclonal antibodies in the lab by isolating the best neutralizing antibodies from CCP samples to create an army of exact replicas that target the COVID-19 virus down to the atomic level, explained Modjarrad. “We know where and how well it’s going to target, and we know the kinetics of how long it will last in the body and how long it will provide protection,” he explained, noting convalescent plasma does not provide that level of effectiveness. “CCP is not generally used for prevention but for treatment.” Monoclonal antibodies could be used for both treatment and prevention of COVID-19 because the transfused neutralizing antibodies would provide immediate immunity, he added.

Monoclonal antibodies have been in use for decades and revolutionized cancer treatment. Krebs’ lab plans to expand the research into monoclonal antibodies against COVID-19 into animal studies this summer. “Our primary goal is to come up with a treatment for people who have COVID-19,” she said.

Anyone able to donate convalescent plasma should contact the Armed Services Blood Program or go online to find a complete list of available collection centers.

You also may be interested in...

Appenzeller emphasizes: Get COVID-19 vaccine, no matter where

Article
4/16/2021
Military personnel explaining forensic equipment

The DHA’s Combat Support assistant director had some direct and encouraging words about the military’s COVID-19 vaccine rollout to date.

Recommended Content:

COVID-19 Toolkit | Coronavirus | COVID-19 Vaccine Toolkit

Tele-critical care will play increased COVID-19 response role in 2021

Article
4/15/2021
Infographic that says "202 tele-critical care successes will help 2021 COVID19 response"

Virtual health and particularly tele-critical care for critically ill patients assumed frontline roles in sustaining care while keeping beneficiaries and health care teams safe.

Recommended Content:

COVID-19 Toolkit | Coronavirus | MHS Transformation

Join Us!! Third COVID-19 Townhall Update with Major General George Appenzeller!

Article
4/13/2021
MHS and Military OneSource COVID-19 Townhall, with Major General (Dr.) George N. Appenzeller.  Wednesday, 14 April, 1 PM ET

Join us for the MHS' Third COVID-19 Townhall with Major General George Appenzeller

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

DOD surpasses 2 million COVID-19 vaccines worldwide

Article
4/9/2021
Military health personnel wearing a face mask and a face shield giving the COVID-19 vaccine

The DOD hit the 2 million mark for vaccinations worldwide just a month after the 1 million milestone.

Recommended Content:

COVID-19 Toolkit | Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

Public health remains an integral part in the fight against COVID

Article
4/9/2021
Infographic featuring health personnel wearing face shields and mask with "National Public Health Week" across the top of the picture

The pandemic has highlighted a need to provide more advanced training on infection prevention and control.

Recommended Content:

COVID-19 Toolkit | April Toolkit | Public Health | Coronavirus | COVID-19 Vaccine Toolkit

Children’s well-being contributes immeasurably to force readiness

Article
4/6/2021
Military personnel wearing face mask in the back of a truck

The Defense Health Agency joins in celebrating military children during Month of the Military Child, observed in April, and always.

Recommended Content:

Children's Health | April Toolkit | Month of the Military Child – Celebrating the Mighty | Coronavirus | Month of the Military Child | Month of the Military Child Image Library

Telemedicine advances put to the test during pandemic

Article
4/1/2021
Uniformed service member stands behind wall of computer screens

COVID-19 has led to the need for physical distancing and has overwhelmed the capacities of health systems, compelling many to adopt telehealth solutions.

Recommended Content:

Technology | Research and Innovation | Coronavirus | COVID-19 Vaccine Toolkit

DOD healthcare leaders give COVID-19 update, praise DHA personnel

Article
3/30/2021
Picture of Director Army Lt. Gen. (Dr. Ronald Place providing a COVID-19 update at  the Pentagon

Dr. Terry Adirim and Army Lt. Gen. (Dr.) Ronald Place provide update on COVID-19 vaccination progress and offer thanks to MHS workers for their contributions.

Recommended Content:

COVID-19 Toolkit | Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

Lovell FHCC staff steps up to create formidable COVID-19 team

Article
3/30/2021
Military health personnel preparing to administer the COVID-19 vaccine

The COVID-19 vaccination effort at the Capt. James A. Lovell Federal Health Care Center in North Chicago, Illinois, has brought out the best in staff.

Recommended Content:

COVID-19 Toolkit | Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

Dover Air Force Base features ‘Park ‘N Pickup’ pharmacy

Article
3/26/2021
Picture of prescription sitting on a counter

Due to the increased need for patient safety, the 436th Medical Group pharmacy at Dover Air Force Base has implemented a Park ‘N Pickup process.

Recommended Content:

Patient Safety Awareness Week | COVID-19 Toolkit | Coronavirus | Patient Safety

DHA Form 207: COVID-19 Vaccine Screening and Immunization Document

Form/Template
3/25/2021

The purpose of this form is to determine if the COVID-19 vaccine can be administered to the patient.

Recommended Content:

COVID-19 Toolkit | Coronavirus | COVID-19 Vaccine Efforts

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Eight nations participate in West African virtual pandemic exercise

Article
3/24/2021
Picture of military personnel wearing a face mask looking at a laptop computer

Medical experts from six African nations, the United Kingdom and the United States, participated in a Virtual Pandemic Preparation and Response Engagement exercise.

Recommended Content:

COVID-19 Toolkit | Coronavirus | Global Health Engagement | Partners

Army dietitian uses nutritional care to fight COVID-19

Article
3/23/2021
Military personnel wearing a face mask standing in front of a Nutrition Clinic

Army dietician plays a critical role in COVID-19 patient recovery.

Recommended Content:

Nutritional Fitness | Total Force Fitness | Coronavirus
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 30

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.